Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: Q4QAW1
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006351 | DNA-templated transcription | 7 | 7 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009058 | biosynthetic process | 2 | 7 |
GO:0009059 | macromolecule biosynthetic process | 4 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0016070 | RNA metabolic process | 5 | 7 |
GO:0018130 | heterocycle biosynthetic process | 4 | 7 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 7 |
GO:0032774 | RNA biosynthetic process | 5 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 7 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0044249 | cellular biosynthetic process | 3 | 7 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0090304 | nucleic acid metabolic process | 4 | 7 |
GO:0097659 | nucleic acid-templated transcription | 6 | 7 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 7 |
GO:1901576 | organic substance biosynthetic process | 3 | 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 7 |
GO:0003746 | translation elongation factor activity | 4 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0008135 | translation factor activity, RNA binding | 3 | 7 |
GO:0045182 | translation regulator activity | 1 | 7 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 169 | 171 | PF00675 | 0.461 |
CLV_NRD_NRD_1 | 279 | 281 | PF00675 | 0.547 |
CLV_NRD_NRD_1 | 42 | 44 | PF00675 | 0.629 |
CLV_NRD_NRD_1 | 70 | 72 | PF00675 | 0.647 |
CLV_PCSK_FUR_1 | 237 | 241 | PF00082 | 0.449 |
CLV_PCSK_KEX2_1 | 169 | 171 | PF00082 | 0.406 |
CLV_PCSK_KEX2_1 | 239 | 241 | PF00082 | 0.454 |
CLV_PCSK_KEX2_1 | 279 | 281 | PF00082 | 0.547 |
CLV_PCSK_KEX2_1 | 42 | 44 | PF00082 | 0.601 |
CLV_PCSK_PC1ET2_1 | 239 | 241 | PF00082 | 0.454 |
CLV_PCSK_PC7_1 | 38 | 44 | PF00082 | 0.574 |
CLV_PCSK_SKI1_1 | 120 | 124 | PF00082 | 0.434 |
CLV_PCSK_SKI1_1 | 162 | 166 | PF00082 | 0.574 |
CLV_PCSK_SKI1_1 | 83 | 87 | PF00082 | 0.515 |
DEG_SCF_FBW7_1 | 59 | 66 | PF00400 | 0.539 |
DOC_MAPK_gen_1 | 225 | 233 | PF00069 | 0.421 |
DOC_MAPK_gen_1 | 71 | 78 | PF00069 | 0.541 |
DOC_USP7_MATH_1 | 160 | 164 | PF00917 | 0.466 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.436 |
DOC_USP7_MATH_1 | 63 | 67 | PF00917 | 0.525 |
DOC_WW_Pin1_4 | 217 | 222 | PF00397 | 0.488 |
DOC_WW_Pin1_4 | 59 | 64 | PF00397 | 0.687 |
LIG_14-3-3_CanoR_1 | 183 | 189 | PF00244 | 0.604 |
LIG_14-3-3_CanoR_1 | 207 | 214 | PF00244 | 0.475 |
LIG_14-3-3_CanoR_1 | 228 | 234 | PF00244 | 0.430 |
LIG_14-3-3_CanoR_1 | 240 | 245 | PF00244 | 0.454 |
LIG_14-3-3_CanoR_1 | 38 | 46 | PF00244 | 0.745 |
LIG_Actin_WH2_2 | 119 | 137 | PF00022 | 0.388 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.627 |
LIG_BRCT_BRCA1_1 | 229 | 233 | PF00533 | 0.363 |
LIG_Clathr_ClatBox_1 | 148 | 152 | PF01394 | 0.473 |
LIG_CtBP_PxDLS_1 | 145 | 149 | PF00389 | 0.418 |
LIG_FHA_1 | 121 | 127 | PF00498 | 0.439 |
LIG_FHA_1 | 187 | 193 | PF00498 | 0.389 |
LIG_FHA_1 | 207 | 213 | PF00498 | 0.514 |
LIG_FHA_1 | 218 | 224 | PF00498 | 0.536 |
LIG_FHA_1 | 284 | 290 | PF00498 | 0.506 |
LIG_FHA_1 | 60 | 66 | PF00498 | 0.545 |
LIG_FHA_2 | 191 | 197 | PF00498 | 0.442 |
LIG_LIR_Gen_1 | 201 | 211 | PF02991 | 0.462 |
LIG_LIR_Nem_3 | 201 | 206 | PF02991 | 0.419 |
LIG_NRBOX | 138 | 144 | PF00104 | 0.341 |
LIG_NRP_CendR_1 | 304 | 305 | PF00754 | 0.462 |
LIG_PCNA_yPIPBox_3 | 183 | 192 | PF02747 | 0.439 |
LIG_PTB_Apo_2 | 202 | 209 | PF02174 | 0.457 |
LIG_Rb_LxCxE_1 | 187 | 209 | PF01857 | 0.335 |
LIG_SH2_GRB2like | 203 | 206 | PF00017 | 0.430 |
LIG_SH2_STAT5 | 180 | 183 | PF00017 | 0.456 |
LIG_SUMO_SIM_anti_2 | 152 | 158 | PF11976 | 0.436 |
LIG_SUMO_SIM_par_1 | 146 | 153 | PF11976 | 0.439 |
MOD_CDK_SPK_2 | 59 | 64 | PF00069 | 0.534 |
MOD_CK1_1 | 137 | 143 | PF00069 | 0.470 |
MOD_CK1_1 | 259 | 265 | PF00069 | 0.474 |
MOD_CK1_1 | 290 | 296 | PF00069 | 0.486 |
MOD_CK1_1 | 37 | 43 | PF00069 | 0.631 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.588 |
MOD_CK1_1 | 49 | 55 | PF00069 | 0.547 |
MOD_CK1_1 | 87 | 93 | PF00069 | 0.454 |
MOD_CK2_1 | 10 | 16 | PF00069 | 0.615 |
MOD_CK2_1 | 190 | 196 | PF00069 | 0.525 |
MOD_CK2_1 | 279 | 285 | PF00069 | 0.531 |
MOD_Cter_Amidation | 237 | 240 | PF01082 | 0.452 |
MOD_GlcNHglycan | 139 | 142 | PF01048 | 0.467 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.446 |
MOD_GlcNHglycan | 258 | 261 | PF01048 | 0.396 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.658 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.606 |
MOD_GlcNHglycan | 89 | 92 | PF01048 | 0.481 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.597 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.457 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.672 |
MOD_GSK3_1 | 186 | 193 | PF00069 | 0.451 |
MOD_GSK3_1 | 279 | 286 | PF00069 | 0.528 |
MOD_GSK3_1 | 287 | 294 | PF00069 | 0.466 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.752 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.616 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.429 |
MOD_N-GLC_1 | 184 | 189 | PF02516 | 0.512 |
MOD_NEK2_1 | 134 | 139 | PF00069 | 0.445 |
MOD_NEK2_1 | 184 | 189 | PF00069 | 0.453 |
MOD_NEK2_1 | 258 | 263 | PF00069 | 0.459 |
MOD_NEK2_1 | 76 | 81 | PF00069 | 0.511 |
MOD_NEK2_1 | 86 | 91 | PF00069 | 0.457 |
MOD_PIKK_1 | 84 | 90 | PF00454 | 0.466 |
MOD_PKA_1 | 279 | 285 | PF00069 | 0.531 |
MOD_PKA_2 | 134 | 140 | PF00069 | 0.436 |
MOD_PKA_2 | 206 | 212 | PF00069 | 0.504 |
MOD_PKA_2 | 227 | 233 | PF00069 | 0.429 |
MOD_PKA_2 | 279 | 285 | PF00069 | 0.531 |
MOD_PKA_2 | 290 | 296 | PF00069 | 0.448 |
MOD_PKA_2 | 37 | 43 | PF00069 | 0.569 |
MOD_PKA_2 | 63 | 69 | PF00069 | 0.599 |
MOD_Plk_1 | 152 | 158 | PF00069 | 0.436 |
MOD_Plk_1 | 160 | 166 | PF00069 | 0.459 |
MOD_Plk_1 | 184 | 190 | PF00069 | 0.554 |
MOD_Plk_1 | 76 | 82 | PF00069 | 0.478 |
MOD_Plk_4 | 134 | 140 | PF00069 | 0.577 |
MOD_Plk_4 | 152 | 158 | PF00069 | 0.291 |
MOD_Plk_4 | 77 | 83 | PF00069 | 0.381 |
MOD_ProDKin_1 | 217 | 223 | PF00069 | 0.482 |
MOD_ProDKin_1 | 59 | 65 | PF00069 | 0.687 |
TRG_DiLeu_BaEn_4 | 146 | 152 | PF01217 | 0.435 |
TRG_ENDOCYTIC_2 | 203 | 206 | PF00928 | 0.430 |
TRG_ER_diArg_1 | 42 | 44 | PF00400 | 0.649 |
TRG_NES_CRM1_1 | 146 | 159 | PF08389 | 0.578 |
TRG_Pf-PMV_PEXEL_1 | 124 | 128 | PF00026 | 0.365 |
TRG_Pf-PMV_PEXEL_1 | 25 | 29 | PF00026 | 0.433 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7Y9 | Leptomonas seymouri | 51% | 100% |
A0A3S7WY11 | Leishmania donovani | 88% | 100% |
E9AH31 | Leishmania infantum | 88% | 100% |
E9AWK9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
V5BVZ7 | Trypanosoma cruzi | 30% | 100% |